Last year, Glaukos Corp generated 421.07M USD for its biggest-performing segment, Glaucoma. The United States made the largest contribution, accounting for 375.04M USD last year. For the latest quarter, Glaukos Corp reported the revenue of 155.18M USD for the period ending 2026-06-30, which came from the top-performing segment, Glaucoma. United States contributed the highest revenue, at 146.74M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Glaucoma

Corneal Health

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Glaucoma

421.07M(82.98%)

303.28M(79.09%)

237.04M(75.32%)

231.98M(78.90%)

179.36M(79.73%)

230.97M(97.46%)

Corneal Health

86.37M(17.02%)

80.20M(20.91%)

77.67M(24.68%)

62.03M(21.10%)

45.60M(20.27%)

6.02M(2.54%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

United States

375.04M(73.91%)

270.09M(70.43%)

219.40M(69.71%)

203.24M(71.85%)

223.79M(76.12%)

173.09M(76.94%)

192.46M(81.21%)

151.68M(83.67%)

International

132.40M(26.09%)

113.39M(29.57%)

95.31M(30.29%)

79.62M(28.15%)

70.22M(23.88%)

51.87M(23.06%)

44.53M(18.79%)

29.60M(16.33%)